Patents by Inventor Gerard P. McNally

Gerard P. McNally has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Translucent antacid suspension containing co-dried dihydroxy aluminum sodium carbonate
    Patent number: 6110505
    Abstract: The invention provides an essentially translucent liquid antacid composition with dihydroxyaluminum sodium carbonate (DASC) as the active ingredient. The DASC is prepared by co-drying DASC with a polyol, and the resulting co-dried DASC/polyol is mixed with water to form the liquid composition. The antacid composition preferably contains additional polyol to further improve the translucency of the liquid composition.
    Type: Grant
    Filed: April 1, 1997
    Date of Patent: August 29, 2000
    Assignee: McNeil PPC Inc.
    Inventors: Bruce P. Smith, John J. Dubek, Gerard P. McNally
  • Methods and compositions for preventing and treating heartburn
    Patent number: 5989588
    Abstract: A method for preventing heartburn episodes in a patient at risk to development of heartburn, comprising administering to the patient, following the heartburn inducing event but prior to development of heartburn, a composition comprising a pharmaceutically effective amount of an H.sub.2 antagonist and an amount of antacid having between about 15 mEq and 46 mEq acid neutralizing capacity.
    Type: Grant
    Filed: September 30, 1997
    Date of Patent: November 23, 1999
    Assignees: Merck & Co., Inc., McNeil-PPC, Inc.
    Inventors: Scott H. Korn, Gerard P. McNally, Joseph R. Luber, Tom S. Ells
  • Liquid antacid compositions
    Patent number: 5976578
    Abstract: Liquid antacid compositions containing a tri- or di-ester buffer have a reduced final product pH providing for a more efficacious preservative system and better tasting product without compromising to acid neutralization capacity of the antacid.
    Type: Grant
    Filed: September 17, 1997
    Date of Patent: November 2, 1999
    Assignee: McNeil-PPC, Inc.
    Inventors: Douglas S. Beyerle, John Case, Gerard P. McNally, Frank Hatch
  • Liquid antacid compositions
    Patent number: 5914135
    Abstract: Calcium carbonate liquid antacid compositions containing one or more pH adjusting agents to maintain the pH above 9.0, preferably above 9.5. The resultant antacid liquid possesses superior resistance to microbial attack and enhanced taste properties.
    Type: Grant
    Filed: April 16, 1997
    Date of Patent: June 22, 1999
    Assignee: McNeil-PPC, Inc.
    Inventors: John J. Dubek, Gerard P. McNally, Bruce P. Smith
  • Translucent antacid suspension
    Patent number: 5874112
    Abstract: An essentially translucent antacid composition is formed by an aqueous colloidal aluminum hydroxide gel wherein the average particle size of the aluminum hydroxide is less than about 0.5 microns, preferably less than about 0.1 microns, and more preferably less than about 0.01 microns. The suspension is further preferably mixed with a polyol, such as sorbitol or maltitol, to enhance the translucency. The weight ratio of polyol to aluminum hydroxide gel (USP) ranges from about 0.5:1.0 to about 4.0:1.0.
    Type: Grant
    Filed: March 31, 1997
    Date of Patent: February 23, 1999
    Assignee: McNeil PPC-Inc.
    Inventors: Gerard P. McNally, John J. Dubek
  • Aqueous antacids with calcium carbonate and magnesium salt
    Patent number: 5631026
    Abstract: The present invention relates to an aqueous pharmaceutical suspension for oral use, and a method of preparation, having antacid and antiulcer properties which contains a therapeutically effective amount of calcium carbonate in combination with magnesium carbonate and/or magnesium trisilicate and a carboxylic acid pH adjusting agent.
    Type: Grant
    Filed: May 31, 1995
    Date of Patent: May 20, 1997
    Assignee: McNeil-PPC, Inc.
    Inventors: Douglas S. Beyerle, Gerard P. McNally
  • Stabilized composition of famotidine and sucralfate for treatment of gastrointestinal disorders
    Patent number: 5593696
    Abstract: Oral dosage forms are disclosed which are effective for treating of gastric disorders. The dosage forms contain, as active ingredients, famotidine and sucralfate. In the dosage form, the famotidine is provided with a barrier layer which prevents interaction between the famotidine and the sucralfate, which improves the stability of the dosage form.
    Type: Grant
    Filed: November 21, 1994
    Date of Patent: January 14, 1997
    Assignee: McNeil-ppc, Inc.
    Inventors: Gerard P. McNally, Edward J. Roche
  • Aqueous antacids with calcium carbonate and magnesium salt
    Patent number: 5455050
    Abstract: The present invention relates to an aqueous pharmaceutical suspension for oral use, and a method of preparation, having antacid and antiulcer properties which contains a therapeutically effective amount of calcium carbonate in combination with magnesium carbonate and/or magnesium trisilicate and a carboxylic acid pH adjusting agent.
    Type: Grant
    Filed: November 12, 1993
    Date of Patent: October 3, 1995
    Assignee: McNeil-PPC, Inc.
    Inventors: Douglas S. Beyerle, Gerard P. McNally